HN2001000011A - Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos. - Google Patents

Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos.

Info

Publication number
HN2001000011A
HN2001000011A HN2001000011A HN2001000011A HN2001000011A HN 2001000011 A HN2001000011 A HN 2001000011A HN 2001000011 A HN2001000011 A HN 2001000011A HN 2001000011 A HN2001000011 A HN 2001000011A HN 2001000011 A HN2001000011 A HN 2001000011A
Authority
HN
Honduras
Prior art keywords
eteres
diabetes
preparation
treatment
methods
Prior art date
Application number
HN2001000011A
Other languages
English (en)
Spanish (es)
Inventor
Ando Howard Yoshihisa
Butler Donald Eugene
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HN2001000011A publication Critical patent/HN2001000011A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HN2001000011A 2000-01-25 2001-01-24 Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos. HN2001000011A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17782300P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
HN2001000011A true HN2001000011A (es) 2001-06-13

Family

ID=22650106

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000011A HN2001000011A (es) 2000-01-25 2001-01-24 Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos.

Country Status (39)

Country Link
EP (1) EP1259474B1 (cg-RX-API-DMAC10.html)
JP (1) JP4750995B2 (cg-RX-API-DMAC10.html)
KR (1) KR20020073182A (cg-RX-API-DMAC10.html)
CN (1) CN1395555A (cg-RX-API-DMAC10.html)
AP (1) AP2002002587A0 (cg-RX-API-DMAC10.html)
AR (1) AR029436A1 (cg-RX-API-DMAC10.html)
AT (1) ATE431326T1 (cg-RX-API-DMAC10.html)
AU (1) AU2214001A (cg-RX-API-DMAC10.html)
BG (1) BG106851A (cg-RX-API-DMAC10.html)
BR (1) BR0107763A (cg-RX-API-DMAC10.html)
CA (1) CA2397960C (cg-RX-API-DMAC10.html)
CO (1) CO5261537A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20022474A3 (cg-RX-API-DMAC10.html)
DE (1) DE60138686D1 (cg-RX-API-DMAC10.html)
DK (1) DK1259474T3 (cg-RX-API-DMAC10.html)
DZ (1) DZ3239A1 (cg-RX-API-DMAC10.html)
EA (1) EA004862B1 (cg-RX-API-DMAC10.html)
EE (1) EE200200404A (cg-RX-API-DMAC10.html)
ES (1) ES2324281T3 (cg-RX-API-DMAC10.html)
GE (1) GEP20053428B (cg-RX-API-DMAC10.html)
GT (1) GT200100015A (cg-RX-API-DMAC10.html)
HN (1) HN2001000011A (cg-RX-API-DMAC10.html)
HU (1) HUP0204422A3 (cg-RX-API-DMAC10.html)
IL (1) IL150541A0 (cg-RX-API-DMAC10.html)
IS (1) IS6442A (cg-RX-API-DMAC10.html)
MA (1) MA26867A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA02007223A (cg-RX-API-DMAC10.html)
NO (1) NO20023526L (cg-RX-API-DMAC10.html)
NZ (1) NZ519550A (cg-RX-API-DMAC10.html)
OA (1) OA12166A (cg-RX-API-DMAC10.html)
PA (1) PA8510601A1 (cg-RX-API-DMAC10.html)
PE (1) PE20011064A1 (cg-RX-API-DMAC10.html)
PL (1) PL357076A1 (cg-RX-API-DMAC10.html)
SK (1) SK10622002A3 (cg-RX-API-DMAC10.html)
SV (1) SV2002000290A (cg-RX-API-DMAC10.html)
TN (1) TNSN01013A1 (cg-RX-API-DMAC10.html)
UY (1) UY26550A1 (cg-RX-API-DMAC10.html)
WO (1) WO2001055078A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200205880B (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1045691T1 (en) * 1997-12-12 2005-04-30 Warner-Lambert Company Llc Statin-carboxyalkylether combinations
JP2006501238A (ja) * 2002-08-22 2006-01-12 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 骨関節炎を治療する方法
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
JPWO2006115130A1 (ja) * 2005-04-19 2008-12-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビス[(2s)−3−[3−[(2s)−3−(4−クロロ−2−シアノフェノキシ)−2−フルオロプロポキシ]フェニル]−2−イソプロポキシプロピオン酸]カルシウム及びその中間体
EP3218349A2 (en) * 2014-11-14 2017-09-20 Gemphire Therapeutics Inc. Processes and intermediates for preparing , -dicarboxylic acid-terminated dialkane ethers
EP3612171A4 (en) 2017-04-18 2020-10-21 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME
JP2022505033A (ja) * 2018-10-18 2022-01-14 ジェムフィアー セラピューティクス インコーポレイテッド ゲムカベン、薬学的に許容されるその塩、その組成物、およびその使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
BR0107763A (pt) 2002-11-12
MXPA02007223A (es) 2002-11-29
IS6442A (is) 2002-06-25
DK1259474T3 (da) 2009-07-20
EA004862B1 (ru) 2004-08-26
WO2001055078A1 (en) 2001-08-02
HUP0204422A2 (en) 2003-05-28
AP2002002587A0 (en) 2002-09-30
MA26867A1 (fr) 2004-12-20
KR20020073182A (ko) 2002-09-19
PA8510601A1 (es) 2002-08-26
NZ519550A (en) 2003-11-28
JP2003520835A (ja) 2003-07-08
ATE431326T1 (de) 2009-05-15
GEP20053428B (en) 2005-01-25
EP1259474A1 (en) 2002-11-27
JP4750995B2 (ja) 2011-08-17
AR029436A1 (es) 2003-06-25
TNSN01013A1 (fr) 2005-11-10
BG106851A (en) 2003-01-31
SV2002000290A (es) 2002-07-16
ES2324281T3 (es) 2009-08-04
CO5261537A1 (es) 2003-03-31
IL150541A0 (en) 2003-02-12
AU2214001A (en) 2001-08-07
NO20023526L (no) 2002-08-27
NO20023526D0 (no) 2002-07-24
PL357076A1 (en) 2004-07-12
CA2397960C (en) 2008-09-09
UY26550A1 (es) 2001-08-27
DZ3239A1 (fr) 2001-08-02
SK10622002A3 (sk) 2003-07-01
CZ20022474A3 (cs) 2003-06-18
DE60138686D1 (de) 2009-06-25
CN1395555A (zh) 2003-02-05
EP1259474B1 (en) 2009-05-13
HUP0204422A3 (en) 2003-08-28
CA2397960A1 (en) 2001-08-02
GT200100015A (es) 2001-10-19
EE200200404A (et) 2003-10-15
PE20011064A1 (es) 2001-10-22
ZA200205880B (en) 2003-07-23
OA12166A (en) 2003-11-07
EA200200641A1 (ru) 2002-12-26

Similar Documents

Publication Publication Date Title
PA8609201A1 (es) Piridinonas sustituidas
ATE343388T1 (de) Pde-v hemmer zur behandlung von morbus parkinson
DE60220422D1 (de) Substituierte pyrazoloverbindungen zur behandlung von entzündungen
AR014261A1 (es) Compuestos hipolipidemicos de benzotiazepina, composiciones y proceso para su preparacion
BR0113039A (pt) Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto
JPS62174059A (ja) ピリミジン誘導体および除草剤
ES8106124A1 (es) Un procedimiento para la pre-paracion de fenoxialcoxifenil- derivados.
DE60021873D1 (de) Zubereitung zur prophylaxe oder behandlung der demenz-erkrankung enthaltend ein hydroxyzimtsäurederivat oder einen extrakt einer pflanze der gattung angelica, der diese säure enthält.
UA82980C2 (ru) Замещенные амиды бензойной кислоты и их применение для угнетения ангиогенеза
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
DE502004006619D1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
ES2150808T3 (es) Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico.
ES2184097T3 (es) Nuevos compuestos.
ATE491453T1 (de) Verwendung von 4-aminochinolin-verbindungen zur behandlung entzündlicher erkrankungen des auges
ES2202156T3 (es) Nuevos analogos de 2-descarboxi-2-fosfinico prostaglandina f.
AR061433A1 (es) Compuestos de amida del acido 3-amino-tieno (2,3,b) piridina -2-carboxilico sustituido, procesos para su preparacion y usos de los mismos
ES2131313T3 (es) Derivados de acido nipecotico como compuestos antitromboticos.
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
UY26550A1 (es) Éteres de dicarboxilato de calcio, métodos para su preparación y tratamiento de las enfermedades vasculares y diabetes con los mismos.
BR0312586A (pt) Derivados de pirolidina como antagonistas e oxitocina
UY26666A1 (es) Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
ATE416174T1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
ES8300332A1 (es) Un procedimiento para la preparacion de nuevos derivados de imidazoquinazolinas
BRPI0417179A (pt) gentisato de amlodipina, método de preparar o mesmo e composição farmacêutica para tratamento de doenças cardiovasculares
ES2169399T3 (es) Procedimiento para preparar heterociclos de fenilo utiles como inhibidores de la cox-2.